Quest Healthcare, a leader in pharmaceutical innovation, proudly announces the launch of MiQuest, the UK’s first AI-driven, medicated prescription skincare service. With over 50 years of combined experience in developing and manufacturing pharmaceuticals, Quest Healthcare is adept in delivering high quality, on time healthcare for patients across the UK.
MiQuest, their latest venture breaks into the skincare market, combining cutting-edge AI technology with dermatology prescriber; pharmacist and formulation scientist – led skincare solutions to address conditions such as acne, rosacea, and pigmentation.
MiQuest offers a unique approach to skincare by utilising AI technology developed by an exceptional team of AI research scientists that analyses face scans to help its formulation scientists develop bespoke delivery systems for powerful prescription ingredients. Additionally, the AI algorithm tracks the severity of the skin concern enabling the customer to keep a track of their condition and allowing the MiQuest formulation scientists to re-optimise the formulation when required, at any point in time during the customers skin journey.
The customer is also required to complete a health questionnaire alongside their face scan, so the MiQuest dermatology team are able to prescribe a fine-tuned, powerful prescription product to the individual skin concern.
Each routine is designed for individual skin profiles, offering targeted treatments through a seamless, subscription-based model. A complete skincare regimen is provided – including a medicated cleanser, moisturiser, and SPF – delivered directly to their door. The process, overseen by prescriber’s pharmacists and formulation scientists, guarantees not only a personalised approach but also clinical efficiency and safety.
Founded 15 years ago and headquartered in Birmingham, Quest Healthcare’s mission has always been to provide efficient and high-quality prescriptions to both private and NHS patients. Facilities licensed by the Department of Health, General Pharmaceutical Council, audited by the NHS and led by a team comprised of prescribers, pharmacists, formulation scientists and academics MiQuest aims to bring unparalleled expertise to the skincare industry.
Providing a personalised, medicated skincare product assists people with certain conditions to overcome lengthy NHS queues as well as providing direct access to experts, who can customise and develop the product to suit the customers changing skin.
By combining powerful AI-driven personalisation with Quest’s extensive pharmaceutical knowledge, MiQuest offers a solution to skin concerns, setting a new standard for both accessibility and effectiveness of bespoke powerful prescription products.
Majad Hussain, founder of MiQuest speaks on his excitement for the release of MiQuest skincare:
“We’re thrilled to introduce MiQuest after an exciting and rigorous period of testing. Our mission is to bridge the gap between science and skincare, offering a way for individuals to access dermatology prescriber, pharmacist and formulation scientist – driven prescription treatments that are both personalised and backed by science.
Using AI technology developed by an exceptional team of AI research scientists, combined with the oversight of experienced academics and scientists, we’ve developed an approach to skincare that is effective, safe and adaptable. This blend of innovation and expertise allows us to offer treatments tailored to each person’s specific needs.
At the heart of MiQuest is our commitment to making high-quality, scientifically informed skincare that is accessible and affordable. We believe that everyone should have the opportunity to benefit from treatments that not only work but are grounded in expert knowledge.”
MiQuest offers a subscription-based service, with customers receiving monthly deliveries of customised skincare.
For a monthly cost of £29.99, users can enjoy a skincare regime designed for their unique skin profile, bypassing long wait times and ineffective over-the-counter options.
